Selected article for: "cytosolic pathway and IFN response"

Author: McWhirter, Sarah M.; Barbalat, Roman; Monroe, Kathryn M.; Fontana, Mary F.; Hyodo, Mamoru; Joncker, Nathalie T.; Ishii, Ken J.; Akira, Shizuo; Colonna, Marco; Chen, Zhijian J.; Fitzgerald, Katherine A.; Hayakawa, Yoshihiro; Vance, Russell E.
Title: A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
  • Document date: 2009_8_31
  • ID: 3b8b8p61_16
    Snippet: We hypothesized that c-di-GMP might be sensed by a cytosolic sensor leading to the induction of type I IFNs. To test this hypothesis, we compared the ability of overlayed versus transfected c-di-GMP to induce type I IFN in bone marrow macrophages. At the concentrations used (up to 25 µg/ml), overlay of c-di-GMP did not elicit a significant response ( Fig. 1 A) , although IFN- production could be detected at higher concentrations (50 or 100 µ.....
    Document: We hypothesized that c-di-GMP might be sensed by a cytosolic sensor leading to the induction of type I IFNs. To test this hypothesis, we compared the ability of overlayed versus transfected c-di-GMP to induce type I IFN in bone marrow macrophages. At the concentrations used (up to 25 µg/ml), overlay of c-di-GMP did not elicit a significant response ( Fig. 1 A) , although IFN- production could be detected at higher concentrations (50 or 100 µg/ml; not depicted). In contrast, delivery of c-di-GMP to the cytosol by transfection elicited robust activation of IFN- in a dose-dependent manner ( Fig. 1 A) . A significant response was detected with a concentration of c-di-GMP as low as 2.5 µg/ml (equivalent to 3.6 µM). These results suggested that c-di-GMP signals via a cytosolic immunosurveillance pathway.

    Search related documents:
    Co phrase search for related documents
    • bone marrow macrophage ifn and marrow macrophage: 1
    • cytosolic sensor and ifn type induction: 1, 2, 3, 4, 5, 6
    • cytosolic sensor and type induction: 1, 2, 3, 4, 5, 6, 7
    • dose dependent manner and high concentration: 1, 2
    • dose dependent manner and hypothesis test: 1, 2, 3
    • dose dependent manner and ifn type induction: 1
    • dose dependent manner and robust activation: 1, 2
    • dose dependent manner and type induction: 1
    • high concentration and hypothesis test: 1, 2, 3, 4, 5, 6
    • high concentration and significant response: 1, 2
    • hypothesis test and significant response: 1
    • ifn type induction and significant response: 1
    • ifn type induction and type induction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77